PHR Stock Analysis: Buy, Sell, or Hold?

PHR - Phreesia, Inc.

SERVICES-BUSINESS SERVICES, NEC
$9.11
0.19 (2.13%) ▲
5d: -0.44%
30d: +3.76%
90d: -22.8%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: May 27, 2026 0d

Get Alerted When PHR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: PHR trading at deep discount. Market pricing in -15.2% annual earnings decline, creating value opportunity for patient investors.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$28.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$17.66
48.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PHR is currently trading at $9.11, which is considered fair relative to its 30-day fair value range of $8.87 to $9.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.9) compared to its historical average (9.7). Remarkably, the market is currently pricing in an annual earnings decline of 15.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PHR is in a strong downtrend. Immediate support is located at $8.76, while resistance sits at $9.66.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.94 (+56.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $8.87 - $9.76
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.7%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 56.3% below Wall St target ($13.94)

Trading Range Analysis

30-Day Trading Range $8.87 - $9.76
Current vs Trading Range FAIR
Expected Move (7 Days) ±$0.79 (8.7%)

Support & Resistance Levels

Support Level $8.76
Resistance Level $9.66
Current Trend Strong Downtrend
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) 5.92
Wall Street Target $13.94 (+56.3%)
Revenue Growth (YoY) 12.9%
Profit Margin 1.8%
Valuation Discount vs History -15.2% cheaper
PE vs Historical 5.9 vs 9.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -15.2% (market-implied from PE analysis)
1-Year Target $8.03 (-10%)
2-Year Target $7.23 (-19%)
3-Year Target $6.50 (-27%)
3-Yr Target (if PE normalizes) (PE: 6→10) $10.65 (+19%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.8, Growth: 29.2%) $70.66 (+692%)
Base: (SPY PE: 5.9, Growth: 29.2%) $19.22 (+115%)
Bear: (PE: 5.0, Growth: 29.2%) $16.33 (+83%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Forward PE: 12.50 | Forward EPS (Implied): $0.71
Bull Case $10.77 (+21%)
Analyst growth 15.0%, PE expands to 13.1
Base Case $8.92 (0%)
Market implied 0.0%, PE stable at 12.5
Bear Case $6.82 (-24%)
Severe decline -15.0%, PE contracts to 11.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.9 to 9.7
Stabilization Target: $14.61 (+63.8%)
PE Expansion Potential: +63.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 10:14 AM ET
Data refreshes hourly during market hours. Next update: 11:14 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison C Hoffman SELL 6176 shares 2026-04-20
Yvonne Hui SELL 1327 shares 2026-04-17
Yvonne Hui SELL 10063 shares 2026-04-16

Unlock Insider Activity

See real-time buying/selling by company executives for PHR.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$245 54 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$31 54 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 57 HOLD
WAY
Waystar Holding Corp. Co…
STRONG BUY
13 analysts
$34 55 HOLD
EVH
Evolent Health Inc
STRONG BUY
14 analysts
$6 57 HOLD

Advanced PHR Option Strategies

Professional options setups generated by AI based on today's PHR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PHR

PHR Technical Chart PHR Price Prediction PHR Earnings Date PHR Investment Advisor PHR Fair Price Analyzer PHR Options Advisor PHR Options Chain PHR Options Analysis PHR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals